Transportation of poorly soluble drug molecules from the organic phase to the aqueous phase by using phosphorylated calixarenes

Journal of Chemical and Engineering Data

Volumn 56, Issue 12, 2011, Pages 4473-4479

  Bayrakc, Mevlüt ^a,b   Ertul, Şeref ^a   Yilmaz, Mustafa ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b NIGDE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AQUEOUS PHASE; CALIXARENES; DRUG MOLECULES; FUROSEMIDES; LIQUID-LIQUID PHASE; NIFEDIPINE; ORGANIC PHASE; POORLY SOLUBLE DRUGS; TRIMETHYL PHOSPHITE; WATER-SOLUBLE CALIXARENE;

CARBOXYLIC ACIDS; LIQUIDS; MICROCRYSTALS; MOLECULES; PHENOLS; PHOSPHORYLATION; PIPE FLOW;

SOLVENT EXTRACTION;

EID: 83455218258     PISSN: 00219568     EISSN: 15205134     Source Type: Journal    
DOI: 10.1021/je2004319     Document Type: Article

References (35)

1. Boje, K. M.; Sak, M.; Fung, H. L. Complexation of nifedipine with substituted phenolic ligands Pharm. Res. 1998, 5, 655-659
2. Reynolds, J. E. F., Ed. Martindale: The extra pharmacopoeia, 29 th ed.; The Pharmaceutical Press: London, 1989; pp 987-991.
3. Kleinbloesem, C. H.; Van Harten, J.; De Leede, L. J. G.; Van Brummelen, P.; Breimer, D. D. Nifedipine: kinetics and dynamics in healthy subjects Clin. Pharmacol. Ther. 1984, 36, 396-401
4. Al-Omar, A.; Abdou, S.; De Robertis, L.; Marsura, A.; Finance, C. Complexation study and anticellular activity enhancement by doxorubicin- cyclodextrin complexes on a multidrugresistant adenocarcinoma cell line Bioorg. Med. Chem. Lett. 1999, 9, 1115-1120
5. Garcia-Rodriguez, J. J.; Torrado, J.; Bolas, F. Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes Parasite 2001, 8, 188-190
6. Uekama, K.; Hirayama, F.; Irie, T. Cyclodextrin drug carrier systems Chem. Rev. 1998, 98, 2045-2076
7. Frömming, K. H.; Szejtli, J. Cyclodextrin in Pharmacy; Kluwer Academic: Dordrecht, 1994.
8. Gutsche, C. D. In Calixarenes Revisited in Monograph in Supramolecular Chemistry; Stoddart, J. F., Ed.; The Royal Society of Chemistry: Cambridge, U.K., 1998.
9. Gutsche, C. D.; Dhawan, B.; Levine, J. A.; No, K. H.; Bauer, L. J. Calixarenes 9: conformational isomers of the ethers and esters of calix[4]arenes Tetrahedron 1983, 39, 409-426
10. Kim, J. S.; Pang, J. H.; Suh, I. H.; Kim, D. W.; Kim, D. W. Novel calix[4]arene dibenzocrown ethers bearing lipophilic alkyl groups symmetrically branched Synth. Commun. 1998, 28, 677-685
11. Bayrakci, M.; Ertul, S.; Yilmaz, M. Synthesis of di-substituted calix[4]arene-based receptors for extraction of chromate and arsenate anions Tetrahedron 2009, 65, 7963-7968
12. Niikura, K.; Anslyn, E. Azacalixarene: synthesis, conformational analysis, and recognition behavior toward anions J. Chem. Soc., Perkin Trans. 1999, 2, 2769-2775
13. Almi, M.; Arduini, A.; Casnati, A.; Pochini, A.; Ungaro, R. Chloromethylation of calixarenes and synthesis of new water-soluble macrocyclic hosts Tetrahedron 1989, 45, 2177-2182
14. Gutsche, C. D.; Alam, I. Calixarenes. 23. The complexation and catalytic properties of water-soluble calixarenes Tetrahedron 1988, 44, 4689-4694
15. Shinkai, S.; Kawabata, H.; Matsuda, T.; Kawaguchi, H.; Manage, O. Synthesis and inclusion properties of neutral water-soluble calixarenes Bull. Chem. Soc. Jpn. 1990, 63, 1272-1274
16. Marra, A.; Scherrmann, M.-C.; Dondoni, A.; Casnati, A.; Minari, P.; Ungaro, R. Sugar calixarenes-preparation of calix[4]arenes substituted at the lower and upper rims with o-glycosyl groups Angew. Chem., Intl. Ed. Engl. 1994, 33, 2479-2481
17. Castro, R.; Godinez, L.; Criss, C.; Kaifer, A. E. Host properties of α-cyclodextrin and a water-soluble calix[6]arene probed with dimeric bipyridinium guests J. Org. Chem. 1997, 62, 4928-4935
18. Shuette, J. M.; Ndou, T. T.; Warner, I. M. Cyclodextrin-induced symmetry of achiral nitrogen heterocycles J. Phys. Chem. 1992, 96, 5309-5314
19. Zhang, Y.; Agbaria, R. A.; Mukundan, N. E.; Warner, I. M. Spectroscopic studies of water-soluble sulfonated calix[6]arene J. Inclusion Phenom. Mol. Recognit. Chem. 1996, 24, 353-365
20. Shinkai, S.; Araki, K.; Manabe, O. Does the calixarene cavity recognize the size of guest molecules? On the hole-size selectivity in water soluble calixarenes J. Chem. Soc., Chem. Commun. 1988, 3, 187-189
21. Durmaz, M.; Yilmaz, M.; Sirit, A. Synthesis of chiral calix[4]arenes bearing aminonaphthol moieties and their use in the enantiomeric recognition of carboxylic acids Org. Biomol. Chem. 2011, 9, 571-580
22. Ertul, S.; Bayrakci, M.; Yilmaz, M. Removal of chromate and phosphate anion from aqueous solutions using calix[4]aren receptors containing proton switchable units J. Hazard. Mater. 2009, 164, 675-682
23. Bayrakci, M.; Ertul, S.; Sahin, O.; Yilmaz, M. Synthesis of two new p-tert-butylcalix[4]arene b -ketoimin derivatives for extraction of dichromate anion J. Inclusion Phenom. Macrocycl. Chem. 2009, 63, 241-247
24. Sayin, S.; Yilmaz, M. Synthesis of a new calixarene derivative and its immobilization onto magnetic nanoparticle surfaces for excellent extractants toward Cr(VI), As(V), and U(VI) J. Chem. Eng. Data 2011, 56, 2020-2029
25. Yang, W.; de Villiers, M. M. The solubilization of the poorly water soluble drug nifedipine by water soluble 4-sulphonic calix[ n ]arenes Eur. J. Pharm. Biopharm. 2004, 58, 629-636
26. Yang, W.; de Villiers, M. M. Effect of 4-Sulphonato-calix[ n ]arenes and Cyclodextrins on the Solubilization of Niclosamide, a Poorly Water Soluble Anthelmintic AAPS J. 2005, 7, 241-248
27. Yang, W.; de Villiers, M. M. Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[ n ]arenes J. Pharm. Pharmacol. 2004, 56, 703-708
28. Xie, D.; Gutsche, C. D. Synthesis and Reactivity of Calix[4]arene-Based Copper Complexes J. Org. Chem. 1998, 63, 9270-9278
29. Berthalon, S.; Regnouf-de-Vains, J.-B.; Lamartine, R. Mono-Functionalization of the tris-(p-tert -Butyl)Calix[4]arene Tetrahedron Lett. 2002, 38, 8527-8528
30. Psychogios, N.; Regnouf-de-Vains, J.-B. A new water-soluble calix[4]arene podand incorporating p -phosphonate groups and 2,2′-bipyridine units Tetrahedron Lett. 2002, 43, 7691-7693
31. Özdemir, N.; Ordu, S. Improvement of dissolution properties of furosemide by complexation with β-cyclodextrin Drug Dev. Ind. Pharm. 1998, 24, 19-25
32. Ammar, H. O.; Ghorab, M.; El-Nahhas, S. A.; Emara, L. H.; Makram, T. S. Inclusion complexation of furosemide in cyclodextrins Die Pharm. 1999, 54, 142-144
33. Guengerich, F. P.; Brian, W. R.; Iwasaki, M.; Sari, M. A.; Baeaernhielm, C.; Berntsson, P. Oxidation of dihydropyridine calcium channel blockers and analogs by human liver cytochrome P-450 IIIA4 J. Med. Chem. 1991, 34, 1838-1844
34. Ali, S. L. In Nifedipine, Analytical Profiles of Drug Substances, Vol. 18; Florey, K., Ed.; Academic Press: New York, 1989; pp 223-288.
35. The Merck Index, 13 th ed.; Merck: Rahway, NY, 2001.